COVID-19 Clinical Neuroscience Study (COVID-CNS)
Addressing the urgent need to understand the biological causes of neurological and neuropsychiatric complications in hospitalised COVID-19 patients.
The study looks to investigate what is driving brain complications in patients with COVID-19 and why do some people develop neurological or neuropsychiatric symptoms whilst others do not.
The COVID-CNS team are actively producing papers for journals with impact; take a look at the most recent articles.
COVID-CNS has six working groups focusing on different research areas of brain complications associated with COVID-19.
Our PPI panel are helping to shape our research study by sharing the patient’s perspective on COVID-CNS. Find out more from the PPI team.